Swinney calls for legal referendum if SNP secures majority at Holyrood election
Writing in a column in the Daily Record, Mr Swinney said that in the 17 years since the 2008 financial crash 'people feel like they are working harder than ever, but not seeing any improvement in their living standards'.
He said the UK economy is 'fundamentally failing to deliver for ordinary people' as well as generating insufficient funding for public services.
The SNP leader called for the May 2026 Holyrood elections to be 'a springboard for Scotland taking charge of our own destiny'.
He said the situation had got worse since the 2014 referendum, and wrote: 'Think what could have been achieved had we not been forced to spend so much time and money trying to mitigate the ongoing damage of Brexit.
'Or the carnage unleashed by Liz Truss's mini-budget. Or the years of austerity, or Westminster cuts like the Winter Fuel Payment.
'We were told we didn't need independence and we just needed a Labour government – but look how that has turned out.'
He wrote that 'independence is the catalyst that will deliver a better future for us all' and that 'with Scotland's energy resources in Scotland's hands, we can reduce bills for consumers and cut costs for businesses'.
Mr Swinney revealed he hoped to deliver an SNP majority similar to 2011 in a bid to 'secure a legal referendum recognised by all' and had submitted a motion to the SNP conference proposing that 'we work to deliver a majority of SNP MSPs in the Scottish Parliament to secure that referendum'.
He pledged to unveil 'radical policies that we know will transform Scotland' in the coming months, and to 'break the logjam and end this frustration that we all feel'.
Mr Swinney added: 'We must be ready to follow the path which we know can lead us to an independent state.'
Scottish Conservative deputy leader Rachael Hamilton said: 'John Swinney is like a broken record. In a bid to silence internal critics of his weak leadership, he has thrown diehard nationalists some more red meat on the one issue they all agree on: independence.
'Ordinary Scots are sick and tired of the SNP's obsession with breaking up the UK.
'The public want John Swinney to focus on fixing the damage his government has done in decimating essential services such as schools and the NHS at the same time as making Scotland the highest taxed part of the UK.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Foreign repression on UK soil rising ‘unchecked', MPs and peers warn
Foreign states are becoming bolder in their attempts to silence dissidents in the UK and the Government must take stronger action, parliamentarians have warned. In a report published on Wednesday, the Joint Committee on Human Rights said transnational repression had increased in recent years, with foreign states using online harassment, lawsuits and physical violence to intimidate people in the UK. MI5 investigations into threats from other states have increased 48% since 2022, the report said, while committee chairman Lord David Alton warned the rise was 'going unchecked'. He said: 'This risks undermining the UK's ability to protect the human rights of its citizens and those who have sought safety within its borders. 'We have seen prominent cases of Hong Kongers with bounties placed on their heads, Iran intimidating journalists – but evidence submitted to the inquiry suggest this may be the tip of the iceberg.' The warning comes amid rising concern about transnational repression, including reports that China has offered rewards for people turning in pro-democracy Hong Kong activists based in the UK. Last month, Parliament's Intelligence and Security Committee warned that Iran had attempted to kidnap or murder at least 15 UK-based people since 2022, while Russia has also targeted dissidents including the attempt to kill Sergei and Yulia Skripal with Novichok in 2018. While the cross-party human rights committee said China, Russia and Iran were the 'most flagrant' perpetrators of transnational repression in the UK, it highlighted evidence suggesting a string of other countries including India, Rwanda, Pakistan, Egypt, Saudi Arabia and Bahrain had sought to target people in Britain. MPs and peers said they had also received 'substantial' evidence of intimidation by the Eritrean government, including surveillance of anti-government activists and infiltration of community groups and churches in an effort to isolate opponents of the regime. The committee went on to criticise Interpol, saying the organisation had refused to acknowledge misuse of 'red notices' – international requests for an arrest – to harass dissidents or take any steps to address this. Almost half of the 6,550 public red notices currently in circulation have been issued at Russia's request. Lord Alton said: 'We want to see a two-pronged approach from the Government. 'More needs to be done to give support and protection to the individuals and communities most at risk of transnational repression. 'We also want to see transnational repression prioritised in diplomatic relations and leadership at an international level to tackle the misuse and exploitation of systems of justice to silence and intimidate.' As well as pressing Interpol for action on abuse of red notices, the committee urged the Government to provide more training on transnational repression for police officers in the UK and greater protection from vexatious lawsuits known as Slapps (strategic lawsuits against public participation). The committee also called for China to be placed in the highest tier of the foreign influence registration scheme that came into effect last month, saying its omission risked 'undermining the credibility and coherence' of the scheme given the extent of Chinese transnational repression. An Interpol spokesperson said: 'Every year, thousands of the world's most serious criminals are arrested thanks to Interpol's systems. 'Children are saved from sexual exploitation and terrorists, cyber criminals and traffickers are brought to justice. 'Interpol knows red notices are powerful tools for law enforcement co-operation, which is why we have robust processes for ensuring that all Interpol notices and diffusions comply with our rules. 'Our constitution forbids Interpol from undertaking activities of a political, military, religious or racial character and all our databases and activities must also comply with the universal declaration for human rights.' A Home Office spokesperson said: 'We take the threat of transnational repression extremely seriously. 'Any attempts by a foreign state to coerce, intimidate, harass, or harm individuals on UK soil are considered a threat to our national security and sovereignty, and will not be tolerated. 'The committee's review echoes many of the same findings and recommendations from the Defending Democracy Taskforce report on TNR, published in May, and we are already taking action arising from those recommendations to further strengthen our response.'
Yahoo
7 hours ago
- Yahoo
AstraZeneca CFO talks tariffs & shifting focus to US market
AstraZeneca's (AZN) revenue hit a record high in the second quarter, driven by cancer drug sales and growth in the US market. AstraZeneca CFO Aradhana Sarin sits down with Market Catalysts host Julie Hyman and Yahoo Finance Senior Healthcare Reporter Anjalee Khemlani to discuss the company's strategy to focus on the US and the impact of tariffs. To watch more expert insights and analysis on the latest market action, check out more Market Catalysts here. I wonder on the Obviously, the company is celebrating the fact that you hit the largest revenues reported for the quarter. That's really good news, especially as the stated goal is to grow by 2030, and half of that to be part of the US. Talk to me about that and the shift to being a quote-unquote American company now, rather than a sort of UK-based one that we've thought of all these years. Uh, so we, you know, last May, we set this ambition of achieving 80 billion in revenues by 2030, which was almost, you know, doubling our revenues from a 2023 base. Um, and, uh, the US is our our fastest growing market. Uh, when we stack, we don't stack very highly right now, uh, in the US when when you compare pharma revenues because a lot of the pharma companies in the US have much bigger sort of revenue base, but we're growing very fast and our hope is that we'll come, you know, in in in the top five and have half of our revenue. We also set an ambition to have 20 new medicines by 2030. And, um, we already have nine of them and, uh, we announced results for another five of them. So hopefully, uh, that shows that we're on track to to achieve that goal. Well, talk to me about why the US is growing that much far faster. Is it because the dynamics of the healthcare system help boost revenues with more prescribing the the way the PBM system is set up? What are the factors that are helping you grow and are helping you stay confident about achieving that goal? So, there are a bunch of different factors. Um, I think the US is still probably the the best market in the world that rewards innovation. Uh, and we are an innovation-driven company. And so, when new therapies come, you know, we we had a product for breast cancer in her two. Uh, we announced data for another breast cancer product. But as soon as new therapy comes, um, the US market is almost the first to provide access to patients for that new therapy. Uh, secondly, physicians are really, um, you know, we go to Congresses like ASCO where there's, you know, tens of thousands of oncology physicians. They're really into, um, looking at the data and making data-driven decisions. So, again, the, you know, the physicians want the best for their patients and patients are able to get access to medicines very quickly once, you know, drug is approved and so forth in the in the innovative space. In many other markets in the world, that whole process to get approval and then get access and reimbursement just takes a very long time. So that's one reason. Um, the second reason, uh, I think particularly beneficial for oncology medicines, uh, is the part D reform. Uh, so on one hand, the part D reform that was enacted hurts us because we are responsible for paying 20% in the catastrophic phase. But from a patient standpoint, if you're a patient, um, you know, in Medicare, your out of pocket is capped at $2,000. So you can get the best therapy and have no more to pay out of pocket, right? So being in that patient population and getting the best access to medicines and the best care and have your out of pocket limited, uh, is is also great for patients. Um, so I think it's it's where physicians and patients and innovation is rewarded. And that's why it's growing faster given our portfolio is all innovative medicines. So, so let's turn then to the manufacturing base rate and the investment that you're making in the US. And I have to ask about tariffs because we even as we discussed it this morning, this new EU sort of framework agreement, it's still sort of unclear. Are pharmaceuticals coming from the EU exempt? Are they not exempt? It seems a little unclear. So how under what assumption are you operating and how do you operate in that kind of environment? Um, yeah, so you know, I would say this is not a tariff is obviously new, but how we've been thinking about our strategic manufacturing, um, is probably goes back three, four years. So post COVID, we made a strategic decision because we're such a global company that we needed to have segregated supply chains. Um, so for example, uh, in in China and in the emerging markets, we supply a lot of that product from China. Um, in the US, majority of the product is supplied from the US and and so forth in Europe. There is, uh, you know, small minority of product, handful of products actually that we still import from Europe into the US. But we do have excess capacity in the US to manufacture those products. Uh, so what we're, you know, we have 11 manufacturing sites in in the US. So our intention once the tariffs, etc. were were announced and there was talks of tariffs, uh, in the short term was just manage through inventory, so build more inventory in in the US. Um, but we've also started tech transfers for those products which we do import and that those tech transfers would be completed, you know, within a within a year or so, so that we can be fully, you know, not just have the majority, but 100% of it being manufactured in in the US. Um, this new facility that we announced, uh, was part of the plan anyway, but that's a separate has nothing to do with tariffs. It's actually based on the demand that we see potentially for our cardiovascular for new cardiovascular medicine. So, um, but you know, you're right, I think there is a little bit of confusion on when the tariffs are going to be implemented. Um, there is from what I've heard, it is a 15%, but there's also talk that that's the cap. Uh, and, uh, the administration is sort of going to wait for the 232 investigation to actually put them into effect or decide. So, uh, in either case, I think we're very well prepared and and we probably have less exposure than than many companies. Related Videos Market's 'fuel' for further P/E expansion is 'nearing empty' Nvidia's TSMC order, Eli Lilly & Novo Nordisk sink, JPMorgan & Apple card Royal Caribbean, Merck, FuboTV: Trending Tickers Why Spotify stock is sinking double digits on Q2 earnings Sign in to access your portfolio
Yahoo
8 hours ago
- Yahoo
US-Based geniant Expands International Footprint With Acquisition of London-Based Brand Experience Studio NewTerritory
Dallas, Texas & London, United Kingdom--(Newsfile Corp. - July 29, 2025) - Today, leading US-based experience consultancy, geniant, has announced its acquisition of NewTerritory, an award-winning UK-based design and brand experience studio founded by former Head of Design for Virgin Atlantic and LG Europe. The London-based team has gained international recognition through multi-sector, visionary projects for clients that include Delta Air Lines, Mercedes-Benz AG, Airbus and Coca-Cola. This move accelerates geniant's global growth strategy while directly addressing a fundamental need in business transformation - the ability to look across all interconnected customer and employee touchpoints, identify the moments that matter most, and then design and deliver next-generation experiences. "As more companies accept that the quality of their customer and employee experiences are key to marketplace success, the real challenge becomes identifying which moments to optimize first - and understanding why they matter," said David Lancashire, geniant's Chairman & Co-CEO. "NewTerritory's expertise in uncovering and shaping those Signature Moments that leave a lasting impression is a powerful addition to geniant's capabilities, strengthening our ability to guide companies toward what truly drives loyalty and impact." Commenting on the deal announcement, Luke Miles, Founder of NewTerritory, said: "Organizations face growing pressure to create distinctive, memorable experiences but often turn to partners unable to deliver at the intersection of creative vision, strategic insights and AI. What drew us to geniant was not just their mastery of these critical capabilities, but a shared belief that the current approach is broken, and that together we can help reimagine better workflows and experiences and actually bring them to life." geniant helps organizations see the big picture, bringing deep insight into customer needs together with a detailed understanding of internal workflows, through its integrated 'Insights, Experiences and AI-First' approach, delivering next-generation experiences. Insights: Proprietary research and analytics pinpoint critical moments that genuinely matter to customers and employees. Experiences: Elevating these moments into unified journeys across digital products, physical environments, and human interactions. AI-First: Guiding enterprises through IT modernization by embedding AI at the heart of products, workflows, and decision-making. Prove value quickly with targeted "lighthouse" projects that build momentum. Prioritize AI investments in alignment with clear business goals to achieve measurable results. Build an adaptive technology foundation that empowers leaders across the enterprise to launch new offerings, streamline operations, and scale with confidence. This cohesive approach enables brands to break free from the "experience echo chamber" and foster authentic, lasting customer and employee loyalty. -ENDS- For media information and editorial images, please contact: hello@ For high resolution copies of these images, please get in touch with the PR contact above: geniant, Chicago Studio To view an enhanced version of this graphic, please visit: New Territory, London Studio To view an enhanced version of this graphic, please visit: Luke Miles, Founder of NewTerritory To view an enhanced version of this graphic, please visit: About NewTerritory NewTerritory is a brand experience studio with capabilities spanning visioning, experience design, and communication. Based in London, the team, guided by data-driven insight, crafts seamless end-to-end experiences that build advocacy and deliver long-term value for brands. Founded by former head of design at Virgin Atlantic, Luke Miles, the studio is recognized for delivering game-changing brands and products within the travel, hospitality, and infrastructure industries. Visit to find out more. About geniant geniant is an experience consultancy helping organizations transform by uniting insights, customer and employee experiences, and AI-first technology. With a proven track record across diverse industries, geniant partners with enterprises to reimagine every touchpoint to deliver measurable business impact. Visit to learn more. To view the source version of this press release, please visit Sign in to access your portfolio
